Lack of Conventional Dendritic Cells Is Compatible with Normal Development and T Cell Homeostasis, but Causes Myeloid Proliferative Syndrome

Immunity

Volumn 29, Issue 6, 2008, Pages 986-997

  Birnberg, Tal ^a   Bar On, Liat ^a   Sapoznikov, Anita ^a   Caton, Michele L ^b   Cervantes Barragán, Luisa ^d   Makia, Divine ^d   Krauthgamer, Rita ^a   Brenner, Ori ^a   Ludewig, Burkhard ^d   Brockschnieder, Damian ^a   Riethmacher, Dieter ^c   Reizis, Boris ^b   Jung, Steffen ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

MOLIMMUNO

Indexed keywords

FLT3 LIGAND; GLYCOPROTEIN P 15095;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; DEVELOPMENT; EXTRAMEDULLARY HEMATOPOIESIS; FEEDBACK SYSTEM; GENE EXPRESSION; HOMEOSTASIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; STEADY STATE; SUICIDE GENE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL PROLIFERATION; DENDRITIC CELLS; HOMEOSTASIS; INTERFERON-GAMMA; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOPROLIFERATIVE DISORDERS; SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 57449109064     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.10.012     Document Type: Article

References (72)

1. Aliberti J., Schulz O., Pennington D.J., Tsujimura H., Reis e Sousa C., Ozato K., and Sher A. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 101 (2003) 305-310
2. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., Rolink A., and Klein L. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8 (2007) 351-358
3. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76 (1998) 34-40
4. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196 (2002) 1627-1638
5. Boscardin S.B., Hafalla J.C., Masilamani R.F., Kamphorst A.O., Zebroski H.A., Rai U., Morrot A., Zavala F., Steinman R.M., Nussenzweig R.S., and Nussenzweig M.C. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203 (2006) 599-606
6. Bousso P., and Robey E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4 (2003) 579-585
7. Boyman O., Purton J.F., Surh C.D., and Sprent J. Cytokines and T-cell homeostasis. Curr. Opin. Immunol. 19 (2007) 320-326
8. Brasel K., McKenna H.J., Morrissey P.J., Charrier K., Morris A.E., Lee C.C., Williams D.E., and Lyman S.D. Hematologic effects of flt3 ligand in vivo in mice. Blood 88 (1996) 2004-2012
9. Brocker T. The role of dendritic cells in T cell selection and survival. J. Leukoc. Biol. 66 (1999) 331-335
10. Brocker T., Riedinger M., and Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185 (1997) 541-550
11. Brockschnieder D., Pechmann Y., Sonnenberg-Riethmacher E., and Riethmacher D. An improved mouse line for Cre-induced cell ablation due to diphtheria toxin A, expressed from the Rosa26 locus. Genesis 44 (2006) 322-327
12. Caton M.L., Smith-Raska M.R., and Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204 (2007) 1653-1664
13. Cervantes-Barragan L., Zust R., Weber F., Spiegel M., Lang K.S., Akira S., Thiel V., and Ludewig B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109 (2007) 1131-1137
14. Cong Y., Konrad A., Iqbal N., Hatton R.D., Weaver C.T., and Elson C.O. Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function. J. Immunol. 174 (2005) 2787-2795
15. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., and Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
16. Dummer W., Ernst B., LeRoy E., Lee D., and Surh C. Autologous regulation of naive T cell homeostasis within the T cell compartment. J. Immunol. 166 (2001) 2460-2468
17. Fehervari Z., and Sakaguchi S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16 (2004) 1769-1780
18. Gallegos A.M., and Bevan M.J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200 (2004) 1039-1049
19. Gallegos A.M., and Bevan M.J. Central tolerance: Good but imperfect. Immunol. Rev. 209 (2006) 290-296
20. Gao E.K., Lo D., and Sprent J. Strong T cell tolerance in parent--F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy. J. Exp. Med. 171 (1990) 1101-1121
21. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 117 (2007) 1195-1203
22. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2005) 953-964
23. Gruber A., and Brocker T. MHC class I-positive dendritic cells (DC) control CD8 T cell homeostasis in vivo: T cell lymphopenia as a prerequisite for DC-mediated homeostatic proliferation of naive CD8 T cells. J. Immunol. 175 (2005) 201-206
24. Hao S.X., and Ren R. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol. Cell. Biol. 20 (2000) 1149-1161
25. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
26. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
27. Holmes R.K. Biology and molecular epidemiology of diphtheria toxin and the tox gene. J. Infect. Dis. 181 Suppl 1 (2000) S156-S167
28. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J.F., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87 (1996) 307-317
29. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17 (2002) 211-220
30. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., and Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369 (1994) 31-37
31. Karsunky H., Merad M., Cozzio A., Weissman I.L., and Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 198 (2003) 305-313
32. Koller B.H., Marrack P., Kappler J.W., and Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248 (1990) 1227-1230
33. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beilhack G.F., Shizuru J.A., and Weissman I.L. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21 (2003) 759-806
34. Krebs P., Scandella E., Odermatt B., and Ludewig B. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J. Immunol. 174 (2005) 4559-4566
35. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., and Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184 (1996) 923-930
36. Kyewski B., and Klein L. A central role for central tolerance. Annu. Rev. Immunol. 24 (2006) 571-606
37. Lee B.H., Tothova Z., Levine R.L., Anderson K., Buza-Vidas N., Cullen D.E., McDowell E.P., Adelsperger J., Frohling S., Huntly B.J., et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12 (2007) 367-380
38. Li L., Piloto O., Nguyen H.B., Greenberg K., Takamiya K., Racke F., Huso D., and Small D. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood 111 (2008) 3849-3858
39. Lindquist R.L., Shakhar G., Dudziak D., Wardemann H., Eisenreich T., Dustin M.L., and Nussenzweig M.C. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5 (2004) 1243-1250
40. Luckashenak N., Schroeder S., Endt K., Schmidt D., Mahnke K., Bachmann M.F., Marconi P., Deeg C.A., and Brocker T. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28 (2008) 521-532
41. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147-154
42. Mahnke K., and Enk A.H. Dendritic cells: Key cells for the induction of regulatory T cells?. Curr. Top. Microbiol. Immunol. 293 (2005) 133-150
43. Mahnke K., Qian Y., Knop J., and Enk A.H. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101 (2003) 4862-4869
44. Maraskovsky E., Pulendran B., Brasel K., Teepe M., Roux E.R., Shortman K., Lyman S.D., and McKenna H.J. Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. Adv. Exp. Med. Biol. 417 (1997) 33-40
45. Mattei F., Schiavoni G., Borghi P., Venditti M., Canini I., Sestili P., Pietraforte I., Morse III H.C., Ramoni C., Belardelli F., and Gabriele L. ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells. Blood 108 (2006) 609-617
46. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C.R., Lynch D.H., Smith J., Pulendran B., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95 (2000) 3489-3497
47. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8 (2007) 1217-1226
48. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., and Manz M.G. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8 (2007) 1207-1216
49. Palucka A.K., Ueno H., Fay J.W., and Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 220 (2007) 129-150
50. Passegue E., Wagner E.F., and Weissman I.L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119 (2004) 431-443
51. Petit I., Goichberg P., Spiegel A., Peled A., Brodie C., Seger R., Nagler A., Alon R., and Lapidot T. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J. Clin. Invest. 115 (2005) 168-176
52. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6 (2005) 280-286
53. Probst H.C., and van den Broek M. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 174 (2005) 3920-3924
54. Rupec R.A., Jundt F., Rebholz B., Eckelt B., Weindl G., Herzinger T., Flaig M.J., Moosmann S., Plewig G., Dorken B., et al. Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity 22 (2005) 479-491
55. Sapoznikov A., Fischer J.A., Zaft T., Krauthgamer R., Dzionek A., and Jung S. Organ-dependent in vivo priming of naive CD4+,but not CD8+,T cells by plasmacytoid dendritic cells. J. Exp. Med. 204 (2007) 1923-1933
56. Sapoznikov A., and Jung S. Probing in vivo dendritic cell functions by conditional cell ablation. Immunol. Cell Biol. 86 (2008) 409-415
57. Scherer M.T., Ignatowicz L., Winslow G.M., Kappler J.W., and Marrack P. Superantigens: Bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9 (1993) 101-128
58. Schiavoni G., Mattei F., Sestili P., Borghi P., Venditti M., Morse III H.C., Belardelli F., and Gabriele L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J. Exp. Med. 196 (2002) 1415-1425
59. Sprent J., Kosaka H., and Gao E.K. T cell tolerance after bone marrow transplantation in mice. Bone Marrow Transplant. 10 Suppl 1 (1992) 5-9
60. Steinman R.M., and Witmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75 (1978) 5132-5136
61. Stirewalt D.L., and Radich J.P. The role of FLT3 in haematopoietic malignancies. Nat. Rev. Cancer 3 (2003) 650-665
62. Tussiwand R., Onai N., Mazzucchelli L., and Manz M.G. Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity. J. Immunol. 175 (2005) 3674-3680
63. Van Etten R.A., and Shannon K.M. Focus on myeloproliferative diseases and myelodysplastic syndromes. Cancer Cell 6 (2004) 547-552
64. van Furth R., and Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128 (1968) 415-435
65. Vremec D., Lieschke G.J., Dunn A.R., Robb L., Metcalf D., and Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27 (1997) 40-44
66. Walkley C.R., Olsen G.H., Dworkin S., Fabb S.A., Swann J., McArthur G.A., Westmoreland S.V., Chambon P., Scadden D.T., and Purton L.E. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129 (2007) 1097-1110
67. Waskow C., Liu K., Darrasse-Jeze G., Guermonprez P., Ginhoux F., Merad M., Shengelia T., Yao K., and Nussenzweig M. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9 (2008) 676-683
68. Watanabe N., Wang Y.H., Lee H.K., Ito T., Wang Y.H., Cao W., and Liu Y.J. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436 (2005) 1181-1185
69. Wernig G., Mercher T., Okabe R., Levine R.L., Lee B.H., and Gilliland D.G. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 107 (2006) 4274-4281
70. Wiktor-Jedrzejczak W., Bartocci A., Ferrante Jr. A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., and Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87 (1990) 4828-4832
71. Yamazaki S., Bonito A.J., Spisek R., Dhodapkar M., Inaba K., and Steinman R.M. Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110 (2007) 4293-4302
72. Zaft T., Sapoznikov A., Krauthgamer R., Littman D.R., and Jung S. CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells. J. Immunol. 175 (2005) 6428-6435